Understanding how patients with heartfailurewith preservedejectionfraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby ...
Data regarding the efficacy and safety of the nonsteroidal mineralocorticoid receptor antagonist finerenone in patients with heartfailure and mildly reduced or preservedejectionfraction ...
An ejectionfraction >35% is unconventional to be considered "preserved," so the results of this trial are inconclusive on whether patients with heartfailure and ejection fractions ...